2019 Jan;62(6):1090-3
Additionally, semaglutide and tirzepatide are both drugs that are currently protected by US patent laws so that the sale of these agents by any unapproved entity is liable to result in a lawsuit from Novo-Nordisk or Ely Lilly
Currently in Phase III clinical trials, retatrutide is a triple agonist, meaning it targets three key metabolic pathways at once, GLP 1, GIP, and glucagon
Related Reading Ozempic For Weight Loss 2 Average Weight Loss On Ozempic Glp 1 For Weight Loss 2 Glp 1 Weight Loss Before And After Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Unlike certain medications such as corticosteroids, beta-blockers, or benzodiazepineswhere abrupt cessation can trigger withdrawal syndromes or rebound effectstirzepatide does not cause physiological dependence or withdrawal symptoms
Some studies have suggested that taking Ozempic may increase someones risk of developing NAION